MedTech Resources

Device type · PYX

Temporary Non-Roller Type Right Heart Support Blood Pump

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about PYX: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

PYX

Cardiovascular

Device class

Class III

FDA decisions since 2015

1

510(k), De Novo and PMA

Adverse event reports

585

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Temporary Non-Roller Type Right Heart Support Blood Pump
Product code
PYX
Device class
Class III
Review panel
Cardiovascular
Regulation
21 CFR 870.4360
Specialty
Cardiology

Latest FDA decisions

All decisions for PYX

Reports received

585

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

168

29% of reports

Injury reports

255

44% of reports

Death reports

162

28% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2311440
Jan 24201220
Feb 24141730
Mar 24231010
Apr 24201950
May 24263950
Jun 24151330
Jul 24171420
Aug 24232230
Sep 24114235560
Oct 2411435280
Nov 243023170
Dec 241325130
Jan 2518980
Feb 25121220
Mar 25111070
Apr 25101470
May 251113100
Jun 252126110
Jul 25152230
Aug 25101260
Sep 257521340
Oct 251924270
Nov 25911110
Dec 25111990
Jan 264030230
Feb 261048330
Mar 262542300
Apr 261522130
May 26111760
Jun 261011160
Jul 2691150
Aug 26122050
Sep 26131790
Oct 263720
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Device Sensing Problem198
  • Patient Device Interaction Problem127
  • Adverse Event Without Identified Device or Use Problem124
  • Restricted Flow rate119
  • Increase in Pressure57
  • Malposition of Device38
  • Pumping Stopped24
  • Failure to Advance20
  • Application Program Problem10
  • Difficult to Remove9

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions239
  • Hemorrhage/Blood Loss/Bleeding106
  • Hemolysis98
  • Hemodynamic instability52
  • Thrombosis/Thrombus38
  • Thromboembolism33
  • Renal Failure27
  • Cardiac Arrest23
  • Hematuria21
  • Thrombocytopenia17

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Abiomed, Inc.

    Z-1469-2026 · Started Jan 27, 2026 · Posted by FDA Feb 27, 2026

    Reason given: Differential pressure (dP) sensor in Impella RP devices may malfunction, causing sensor values to drift.

    Cause as FDA categorized it: Under Investigation by firm

  • Abiomed, Inc.

    Z-1470-2026 · Started Jan 27, 2026 · Posted by FDA Feb 27, 2026

    Reason given: Differential pressure (dP) sensor in Impella RP devices may malfunction, causing sensor values to drift.

    Cause as FDA categorized it: Under Investigation by firm

  • Abiomed, Inc.

    Z-1471-2026 · Started Jan 27, 2026 · Posted by FDA Feb 27, 2026

    Reason given: Differential pressure (dP) sensor in Impella RP devices may malfunction, causing sensor values to drift.

    Cause as FDA categorized it: Under Investigation by firm

  • Abiomed, Inc.

    Z-0829-2025 · Started Dec 12, 2024 · Posted by FDA Jan 15, 2025

    Reason given: Optical Sensors have been damaged due to physical interaction between the inlet and another device resulting in a Placement Signal Not Reliable (PSNR) alarm and loss of Central Venous (CV) Placement Signal, Pulmonary Artery (PA) Placement Signal & Pulmonary Artery Pulse Index (PAPi) metrics. Abiomed is reinforcing...

    Cause as FDA categorized it: Under Investigation by firm

  • Abiomed, Inc.

    Z-0830-2025 · Started Dec 12, 2024 · Posted by FDA Jan 15, 2025

    Reason given: Optical Sensors have been damaged due to physical interaction between the inlet and another device resulting in a Placement Signal Not Reliable (PSNR) alarm and loss of Central Venous (CV) Placement Signal, Pulmonary Artery (PA) Placement Signal & Pulmonary Artery Pulse Index (PAPi) metrics. Abiomed is reinforcing...

    Cause as FDA categorized it: Under Investigation by firm

  • Abiomed, Inc.

    Z-0636-2024 · Started Dec 6, 2023 · Posted by FDA Jan 4, 2024

    Reason given: The following features have been disabled from the web-based portal because the FDA has not evaluated these features for safety and effectiveness: Notifications via email feature; AIC alarm color on case tile feature; Sort case tiles by AIC alarm color feature; Pump metric display on case tile feature

    Cause as FDA categorized it: No Marketing Application

  • Abiomed, Inc.

    Z-2281-2023 · Started Jun 29, 2023 · Posted by FDA Aug 3, 2023

    Reason given: A higher than expected rate of thrombus formation or deposition has been observed. The risk is for thrombus formations or deposits on indwelling central venous lines or cannulas may break free and enter into the Impella RP Flex, resulting in reduced flow, loss of support, or hemolysis

    Cause as FDA categorized it: Under Investigation by firm

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.